Results 201 to 210 of about 45,700 (265)

Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS‐HF

open access: yesEuropean Journal of Heart Failure, EarlyView.
CV, cardiovascular, HF, heart failure; K+, serum potassium; eGFR, estimated glomerular filtration rate. Aims Finerenone improved heart failure (HF) outcomes in patients with heart failure and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF). Clinical decision‐making around initiation of mineralocorticoid receptor antagonists often relies on
João Pedro Ferreira   +17 more
wiley   +1 more source

Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT‐HF registry

open access: yesEuropean Journal of Heart Failure, EarlyView.
Global patterns of polypharmacy after acute heart failure hospitalization. GDMT, guideline‐directed medical therapy; HF, heart failure. Aims Polypharmacy, defined as the concurrent use of ≥5 medications, is prevalent among older adults with heart failure (HF).
Wan Ting Tay   +19 more
wiley   +1 more source

The Effect of Glucocorticoid and Mineralocorticoid Receptor Antagonists in the Skin of Aged Female Mice. [PDF]

open access: yesInt J Mol Sci
Ali A   +8 more
europepmc   +1 more source

A U‐shaped relationship between left ventricular ejection fraction and risk of worsening heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
A U‐shaped relationship between left ventricular ejection fraction (LVEF) and clinical outcomes. A U‐shaped relationship can be observed between LVEF, the primary outcome, and the cardiovascular‐related outcomes, including cardiovascular death and the risk of worsening heart failure (HF).
Hao‐Chih Chang   +9 more
wiley   +1 more source

European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action

open access: yesEuropean Journal of Heart Failure, EarlyView.
Heart failure (HF) and atrial fibrillation (AF) are major global health challenges with rising prevalence and significant morbidity, mortality, and healthcare burden. Despite advances in HF management, AF remains a critical comorbidity that worsens outcomes and requires ad hoc treatment strategies, increasing the risk of non‐adherence and side effects.
Mark Luedde   +24 more
wiley   +1 more source

Neutrophil‐to‐lymphocyte ratio for risk stratification in acute myocarditis across the left ventricular ejection fraction spectrum

open access: yesEuropean Journal of Heart Failure, EarlyView.
Illustration defining the criteria for high‐risk acute myocarditis (AM), incorporating haemodynamic compromise, life‐threatening arrhythmias, and reduced left ventricular ejection fraction (LVEF <40%). Neutrophil‐to‐lymphocyte ratio (NLR) ≥4 is an independent risk marker, including among patients with preserved LVEF (≥50%) at presentation, where ...
Cristina Madaudo   +37 more
wiley   +1 more source

Artificial intelligence‐based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis

open access: yesEuropean Journal of Heart Failure, EarlyView.
Artificial intelligence (AI)‐based estimation of stroke volume for risk prediction in amyloid transthyretin cardiomyopathy (ATTR‐CM). ATTRv, hereditary transthyretin amyloidosis; ATTRwt, wild‐type transthyretin amyloidosis; CI, confidence interval; HR, hazard ratio; IQR, interquartile range; LVOT‐VTI, left ventricular outflow tract velocity‐time ...
Lucia Venneri   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy